Primary Site >> Colorectal Cancer
Gene >> FUT4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues. PMID: 3516383 |
Ref: Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancer. PMID: 2479331 Ref: [Glycoproteins associated with metastatic potential of cancer]. PMID: 2572199 Ref: Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. PMID: 2573422 |
Ref: Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. PMID: 1979361 Ref: Carbohydrate antigen expression in colorectal cancer. PMID: 2103494 Ref: Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. PMID: 2302060 Ref: Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. PMID: 2302702 |
Ref: Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. PMID: 1673088 Ref: Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. PMID: 1679016 Ref: Ectopic expression of mucins in colorectal cancer metastasis. PMID: 1680492 Ref: Biosynthesis in vitro of SA-Lex and SA-diLex by alpha 1-3 fucosyltransferases from colon carcinoma cells and embryonic brain tissues. PMID: 1726578 Ref: [Carbohydrate antigens as a tumor-associated antigen and prognostic indicators in carcinomas of the breast, esophagus, stomach, colorectum, and pancreas]. PMID: 1944163 |
Ref: Immunohistochemical demonstration of glycoconjugates bearing the type 2 chain-backbone structure in human fetal, normal and neoplastic gastrointestinal tract. PMID: 1618643 |
Ref: Carbohydrate antigens and liver metastasis in colorectal cancer. PMID: 7904324 Ref: Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. PMID: 8104679 |
Ref: Significance of MUC1 and MUC2 mucin expression in colorectal cancer. PMID: 8813954 Ref: [Lewis antigens in human colon carcinoma]. PMID: 9072776 Ref: [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells]. PMID: 9163103 |
Ref: Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells. PMID: 9268986 Ref: Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. PMID: 9405606 Ref: Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients. PMID: 9568546 |
Ref: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. PMID: 9499461 Ref: Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. PMID: 9690558 Ref: Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection. PMID: 9732216 Ref: Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-Lewis(a) structure. PMID: 9878545 |
Ref: The relationship between circulating sialyl Tn antigen and polypoid or nonpolypoid growth characteristics in colorectal cancer. PMID: 11003566 Ref: Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer. PMID: 11064310 |
Ref: Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. PMID: 11165714 |
Ref: [Expression of leucocyte cell-surface antigens on colon cancer cell line HR8348]. PMID: 15067730 |
Ref: Prognostic value of multimarker analysis in stage III colorectal cancer: one step forward towards an individualized therapy decision. PMID: 16160402 |
Ref: Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin. PMID: 16850248 Ref: Activation of human peritoneal immune cells in early stages of gastric and colon cancer. PMID: 17263978 |
Ref: Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin. PMID: 19788442 Ref: Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. PMID: 20179215 Ref: The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. PMID: 21059221 |
Ref: Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma. PMID: 21473743 Ref: Prognostic role of CD10(+) myeloid cells in association with tumor budding at the invasion front of colorectal cancer. PMID: 21599811 |
Ref: Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer. PMID: 21773689 |
Ref: Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PMID: 23437326 Ref: High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PMID: 23734221 Ref: The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development. PMID: 24009629 |
Ref: Interleukin-17 is a favorable prognostic marker for colorectal cancer. PMID: 25015721 Ref: Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. PMID: 25823653 Ref: Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer. PMID: 26427914 |
Ref: A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer. PMID: 26581202 Ref: Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer. PMID: 27006653 Ref: Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients. PMID: 28008330 |
Ref: [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology]. PMID: 28471197 Ref: Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. PMID: 28640257 |
Ref: Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data. PMID: 29721106 Ref: Increased number of arginase 1-positive cells in the stroma of carcinomas compared to precursor lesions and nonneoplastic tissues. PMID: 29970307 Ref: Immune Condition of Colorectal Cancer Patients Featured by Serum Chemokines and Gene Expressions of CD4+ Cells in Blood. PMID: 29992127 |